| # | Drug | Count |
|---|---|---|
| 0 | EXENATIDE | 7 |
| 1 | ASPIRIN | 6 |
| 2 | ASPIRIN 325 MG | 6 |
| 3 | ASPIRIN 81 MG | 6 |
| 4 | DIAZEPAM | 6 |
| 5 | ESOMEPRAZOLE MAGNESIUM | 6 |
| 6 | PEGINTERFERON ALFA-2A | 6 |
| 7 | ACETAMINOPHEN | 5 |
| 8 | ALBUTEROL SULFATE | 5 |
| 9 | ARIPIPRAZOLE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGUNIGALSIDASE ALFA | 1 | 0.0027 |
| 1 | CHROMIC CHLORIDE | 1 | 0.0012 |
| 2 | SELENIUM SULFIDE | 1 | 0.0011 |
| 3 | HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX | 1 | 0.0010 |
| 4 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 1 | 0.0005 |
| 5 | ARSENIC TRIOXIDE | 1 | 0.0004 |
| 6 | INSULIN GLARGINE AND LIXISENATIDE | 1 | 0.0003 |
| 7 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 3 | 0.0002 |
| 8 | CYPROHEPTADINE HYDROCHLORIDE | 1 | 0.0002 |
| 9 | REGADENOSON | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 1 | Benzodiazepine [EPC] | 9 |
| 2 | Corticosteroid [EPC] | 9 |
| 3 | GLP-1 Receptor Agonist [EPC] | 8 |
| 4 | Osmotic Laxative [EPC] | 6 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 6 |
| 6 | Atypical Antipsychotic [EPC] | 5 |
| 7 | Vitamin C [EPC] | 5 |
| 8 | Insulin Analog [EPC] | 4 |
| 9 | Interferon beta [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adenosine Receptor Agonist [EPC] | 1 | 0.0001 |
| 1 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 2 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 4 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |
| 5 | Iron Chelator [EPC] | 1 | 0.0000 |
| 6 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 7 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Sulfonylurea [EPC] | 3 | 0.0000 |
| 9 | Nucleoside Analog Antiviral [EPC] | 2 | 0.0000 |